skip to Main Content
Phone: 301-655-1084 Email: info@glycomantra.com

July 18, 2018

GlycoMantra received SBIR Phase 1 grant from the NCI (NIH)

GlycoMantra was awarded SBIR Phase 1 grant to investigate drug resistance in metastatic prostate cancer.

Back To Top